News & Updates

Experimental gene therapy appears to improve eyesight in patients with a severe progressive form of Leber’s hereditary optic neuropathy (LHON) in an early access programme.

A study from the University of California reports a 226 percent statistically significant improvement in verbal learning and memory in older adults with normal cognition using nighttime olfactory enrichment.

In patients with nonvalvular atrial fibrillation (NVAF) who experience ischaemic stroke (IS) while on a direct oral anticoagulant (DOAC), continuing treatment with the same DOAC is more effective at preventing recurrent IS than switching to a different DOAC or warfarin, a Hong Kong population-based retrospective cohort study has shown.

New drug applications approved by US FDA as of 16-31 July 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Children with type 2 diabetes (T2D) face a strikingly high complication rate as they become young adults, with an 80 percent incidence of at least one vascular complication, as shown in the TODAY* study.

There is no evidence to suggest that treatment with tranexamic acid (TXA) helps limit hematoma expansion in patients with intracerebral haemorrhage (ICH) associated with nonvitamin K antagonist oral anticoagulants (NOACs), according to a study.